LPTX
Price:
$0.7696
Market Cap:
$36.84M
Leap Therapeutics, Inc. is a biopharmaceutical firm dedicated to discovering and advancing treatments for various cancers. At the forefront of its pipeline is DKN-01, a monoclonal antibody designed to block Dickkopf-related protein 1 (DKK1). This investigational therapy is currently undergoing several clinical trials, targeting a range of malignancies such as esophagogastric, hepatobiliary, gynecologic, and prostate cancers. Leap Therapeutics has also forged an option and licensing partnership with BeiGene, Ltd., granting them rights to develop and market DKN-01 across Asia (excluding Japan), Australia, and New Zealand. Established in 2011, the company initially operated as HealthCare Pharma...[Read more]
Industry
Biotechnology
IPO Date
2017-01-25
Stock Exchange
NASDAQ
Ticker
LPTX
According to Leap Therapeutics, Inc.’s latest financial reports and current stock price. The company's current ROE is -46.86%. This represents a change of -47.61% compared to the average of -89.44% of the last 4 quarters.
The mean historical ROE of Leap Therapeutics, Inc. over the last ten years is -102.18%. The current -46.86% ROE has changed -54.14% with respect to the historical average. Over the past ten years (40 quarters), LPTX's ROE was at its highest in in the December 2019 quarter at 51.29%. The ROE was at its lowest in in the June 2025 quarter at -291.11%.
Average
-102.18%
Median
-80.06%
Minimum
-267.40%
Maximum
25.57%
Discovering the peaks and valleys of Leap Therapeutics, Inc. ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 648.69%
Maximum Annual ROE = 25.57%
Minimum Annual Increase = -1145.64%
Minimum Annual ROE = -267.40%
| Year | ROE | Change |
|---|---|---|
| 2025 | 3.14% | -101.63% |
| 2024 | -192.75% | 42.39% |
| 2023 | -135.37% | 35.49% |
| 2022 | -99.92% | 165.59% |
| 2021 | -37.62% | 648.69% |
| 2020 | -5.02% | -91.66% |
| 2019 | -60.21% | -76.12% |
| 2018 | -252.19% | -5.69% |
| 2017 | -267.40% | -1145.64% |
| 2016 | 25.57% | -132.56% |
The current ROE of Leap Therapeutics, Inc. (LPTX) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages
3-year avg
-108.33%
5-year avg
-92.50%
10-year avg
-102.18%
Leap Therapeutics, Inc.’s ROE is greater than Citius Pharmaceuticals, Inc. (-67.42%), greater than Athira Pharma, Inc. (-381.01%), less than Curis, Inc. (805.67%), greater than Processa Pharmaceuticals, Inc. (-281.30%), less than Apollomics, Inc. (288.40%), greater than SeaStar Medical Holding Corporation (-146.29%), greater than BriaCell Therapeutics Corp. (-147.92%), less than Aspire Biopharma Holdings, Inc. (199.43%), greater than Entero Therapeutics, Inc. (-18.69%), less than Daré Bioscience, Inc. (763.44%),
| Company | ROE | Market cap |
|---|---|---|
| -67.42% | $6.03M | |
| -381.01% | $26.62M | |
| 805.67% | $5.55M | |
| -281.30% | $4.92M | |
| 288.40% | $15.78M | |
| -146.29% | $8.46M | |
| -147.92% | $5.22M | |
| 199.43% | $572.25K | |
| -18.69% | $13.58M | |
| 763.44% | $19.23M |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Leap Therapeutics, Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Leap Therapeutics, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the ROE?
How can you use the ROE?
What is Leap Therapeutics, Inc.'s ROE?
How is the ROE calculated for Leap Therapeutics, Inc. (LPTX)?
What is the highest ROE for Leap Therapeutics, Inc. (LPTX)?
What is the 3-year average ROE for Leap Therapeutics, Inc. (LPTX)?
What is the 5-year average ROE for Leap Therapeutics, Inc. (LPTX)?
How does the current ROE for Leap Therapeutics, Inc. (LPTX) compare to its historical average?